posdinemab

News

Hopes that anti-tau drugs could emerge as treatments for Alzheimer's have been dented by the failure of a phase 2b trial of J&J's posdinemab.

News

The NHS will include an AI-powered triage tool in the NHS App in an attempt to cut waiting lists and improve care for millions of patients.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.